We are excited to share that Professor Tore Bengtsson and Dr. Hamza Bokhari will be attending Endocrine Metabolic GPCRs 2026 in Liverpool (9–10 Feb)!
Hamza will be presenting our latest research:
“A GRK-Biased β₂-Adrenergic Receptor Agonist Induces Coordinated Fat Loss and Muscle Gain via Pathway-Selective Signaling.”
Our work underscores how pathway-selective GPCR modulation can drive favorable metabolic outcomes while minimizing adverse effects, which has exciting implications for metabolic diseases and muscle wasting.
Looking forward to engaging discussions and new collaborations at EMGPCRs2026!
More about the conference: https://www.endocrinology.org/events/endocrine-metabolic-gpcrs/endocrine-metabolic-gpcrs-2026
